Lessee, Operating Lease, Liability, to be Paid, Year Four of Shuttle Pharmaceuticals Holdings, Inc. from 31 Dec 2023 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary: Shuttle Pharmaceuticals Holdings, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD history and change rate from 31 Dec 2023 to 31 Dec 2024.
Shuttle Pharmaceuticals Holdings, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Dec 2024 was $68,235, a 32% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

Shuttle Pharmaceuticals Holdings, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$68,235	-$31,751	-32%	31 Dec 2024	10-K	26 Feb 2025	2024	FY
Q3 2024	$68,235			30 Sep 2024	10-Q	13 Nov 2024	2024	Q3
Q2 2024	$68,235			30 Jun 2024	10-Q	04 Sep 2024	2024	Q2
Q1 2024	$68,235			31 Mar 2024	10-Q/A	04 Sep 2024	2024	Q1
Q4 2023	$99,986			31 Dec 2023	10-K/A	04 Sep 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.